Delivery Order SPE2DB22D3501-SPE2DB24FVS92

Award Date 5/21/24
Potential Completion Date 6/12/24
Potential Value $4.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of the drug Benlysta 120 mg vials. The contract has a ceiling value of $5,051.50 and is a firm-fixed-price delivery order that runs through May 14, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of BENLYSTA 400 MG VIALS, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $12,595.00 and an ultimate completion date of June 18, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) the company holds with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
The U.S. Defense Logistics Agency (DLA) awarded a $2,275.20 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of 120 mg vials of Benlysta, a prescription medication. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop Support Medical for providing a comprehensive range of pharmaceutical and medical supplies to support military healthcare programs. The contract has an...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the supply of the drug BENLYSTA 400 mg vials. The award, valued at $2,519.00, is a delivery order contract with a firm fixed price. The contract has an ultimate completion date of June 6, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Benlysta 120 mg vials, a specialty medication, with a ceiling value of $2,370.06 and a period of performance through February 19, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,424.24 firm fixed-price delivery order is for 400 mg vials of the specialty medication BENLYSTA. The contract has an ultimate completion date of January 10, 2025. This award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, is a delivery order valued at $13,854.50 for the supply of 400 mg vials of the medication BENLYSTA. The award was issued by the Defense Logistics Agency (DLA), a defense agency within the Department of Defense. The contract does not have a set-aside designation and is a firm fixed price delivery order with an ultimate completion date of April 29, 2024. Amerisourcebergen Drug Corp is...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,519.00 firm fixed-price delivery order is for the supply of BENLYSTA 400 MG vials, a specialty medication. The contract has a period of performance through November 19, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a $5,779.12 firm fixed-price delivery order for the supply of Benlysta 200 mg/mL auto-injectable medication. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, and has an ultimate completion date of December 13, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Benlysta 200 mg/ml autoinjectors. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FVS92
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a large pharmaceutical distribution company. The award is for the provision of 120 mg vials of the drug Benlysta, under a Delivery Order contract with a Firm Fixed Price pricing type. The total ceiling value of the contract is $4,550.40, with a completion date of June 12, 2024.

This award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this single-award IDC, Amerisourcebergen serves as the primary supplier of a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense globally. The contract does not have a set-aside designation.

Generated 8/20/24, 9:30 AM